Cutaneous hypersensitivity responses to brucella antigens of different composition were studied in guinea pigs sensitized by infection with smooth brucella or immunization with killed rough brucella in adjuvant. These 
Although the ability of proteins to induce and elicit specific delayed-hypersensitivity reactions is generally recognized, there is controversy surrounding the role of polysaccharides (PS; 3) and lipopolysaccharides (LPS; 8) that are unassociated with proteins. Most brucella allergens contain varying amounts of LPS in addition to proteins and nucleoproteins (2) . Others consist almost entirely of PS (15) . Since animals infected with brucella usually have serum antibodies to PS determinants of the cell wall LPS, it is possible that dermal reactions to some allergens involve overlapping antibodymediated and delayed-type reactions.
Preparations of brucella LPS contain lipid A (13) as well as varying amounts of polypeptide, some of which is tightly bound (M. S. Redfearn, Ph.D. thesis, Univ. of Wisconsin, Madison, 1960) . Previous studies on the dermal response of sensitized guinea pigs to brucella LPS (10) suggested that the inflammation was a combination of reactions comprising those due to the toxicity of lipid A and specific delayed hypersensitivity to the polypeptide associated with the antigen. In the present study, a brucella PS antigen that had minimal toxicity for normal guinea pigs was examined concurrently with LPS antigens. These antigens, containing varying amounts of protein, were compared with a protein allergen that lacked LPS components. The experiments were designed to determine 36C
whether brucella LPS and PS elicit delayed hypersensitivity reactions, or whether the dermal reactions elicited by these antigens are antibody mediated in whole or in part.
MATERIALS AND METHODS Bacterial strains. All brucella cultures have been used in our previous studies (4, 5 (5) .
Antigens. Protein (P) antigen was prepared from B. melitensis rough strain B115 by extraction in cold saline (2) and characterized as a heat-stable protein allergen containing no detectable LPS (12) . Protein content, as determined by the Lowry method (19), was 56%.
Two different preparations of LPS antigen, extracted from B. melitensis smooth strain 16M by the modified hot phenol-water method (14) , were used. LPS-1 contained 25% protein. LPS-2 had been sedimented at 60,000 x g for 12 h and contained 5% protein.
PS antigen was prepared from B. abortus smooth strain 1119-3 by a method (15) (11) .
ACA. Infected and adjuvant-immunized guinea pigs were injected intradermally with 0.1 ml of several doses of three or more antigens immediately after the intracardial injection of 0.5 ml of 1% Evan's blue in 0.85% saline (16) . A blue ring appearing within a few minutes at the intradermal site of one of the antigens indicated that the intracardial injection had been successful. An intradermal injection of saline was included on each animal as a control to rule out the possibility of nonspecific bluing reactions. The animals were observed for 30 min. Normal guinea pigs given intracardial injections of Evan's blue followed by intradermal injections with the same antigens did not develop bluing reactions.
Passive cutaneous anaphylaxis (PCA). Individual or pooled sera from normal, infected, and immunized guinea pigs, taken before intradermal or ACA tests, were diluted 1:25, 1:100, and 1:400, and 0.1 ml was injected intradermally into normal guinea pigs (16) . Serum dilutions heated for 30 min at 56 C were also injected with unheated serum dilutions on some animals. Three to 4 h later the animals were injected intracardially with 1 ml containing 100 to 500 jug of one of the antigens and 0.5 ml of 1% Evan's blue solution. Only those guinea pigs showing a bluing reaction at at least one of the intradermal sites within 30 min were included in the results.
RESULTS
Antigenic analysis. Analysis of the brucella LPS preparation by immunoelectrophoresis with hyperimmune anti-smooth brucella serum showed slowly diffusing lines with the characteristic cathodic mobility that have been identified as LPS antigens (4), as well as several fast-moving lines associated with the P antigens (4). The PS antigen developed only a single line with cathodic mobility similar to that observed with LPS. The P antigen preparation did not develop the LPS line with the anti-smooth brucella serum from infected animals or those hyperimmunized with either smooth or rough organisms. P antigen developed a number of lines, as illustrated previously (12), when tested with either hyperimmune anti-smooth or antirough sera.
Immunodiffusion tests were set up to determine the cross-reactivity of the LPS and PS lines, as well as the identity of the P components, in the various antigenic preparations. Table 1 summarizes the numbers of lines observed with all of the combinations of sera and antigens. It shows that sera from rabbits hyperimmunized with killed rough B. abortus did not precipitate with PS or yersinia antigens and that sera from rabbits infected with smooth B. abortus did not precipitate with brucella P antigen. Sera from rabbits hyperimmunized with killed smooth B. abortus precipitated with all of the antigens except Y. enterocolitica type 8 LPS, which was not precipitated with any of the sera. Figure 1 is from a representative experiment with sera from rabbits infected with smooth B. abortus. It illustrates the reaction of identity of one of the components of each of LPS-1 and yersinia type 9 LPS with the single component in brucella LPS-2 and PS antigens.
Sera from rabbits hyperimmunized with killed rough brucella developed reactions of identity with at least one of the lines in brucella P, LPS-1, and LPS-2 antigens. The reactions with guinea pig sera were the same as those with the rabbit sera. That is, sera from infected guinea pigs had precipitins to the 9 LPS, but negative reactions to P or yersinia type 8 LPS (Table 3) . In contrast, the guinea pigs immunized with rough brucella in adjuvant had positive ACA reactions only with the P and LPS antigens containing the brucella proteins.
PCA. Sera from infected guinea pigs produced positive PCA reactions in all animals injected intracardially with PS antigen, in some animals injected with LPS antigen, but in none of the animals given P antigen (Table 4) .
Sera from adjuvant-immunized guinea pigs produced positive PCA reactions in animals injected intracardially with P and LPS antigens. Sera from adjuvant-immunized guinea pigs were absorbed with P antigen. These absorbed sera did not give PCA reactions with either P or LPS antigens, although the unabsorbed sera tested on the same animals were positive with these antigens. This indicated that the P component in LPS was antigenically the same as that in P antigen.
Serum dilutions that had been heated gave the same results as nonheated serum dilutions tested simultaneously on the same guinea pigs, i.e., positive at a 1:100 dilution. This minimizes the probability that immunoglobulin E was involved. LPS by absorbing sera with P antigen shows that the antibody-mediated reactions in these animals are to the P component. These antibody-mediated reactions can interfere with the quantification and interpretation of the delayed-type hypersensitivity response to P antigen. It seems clear from these results that it is preferable to use infected, rather than adjuvant-immunized, guinea pigs for the standardization of antigens for delayed-type hypersensitivity testing in brucellosis.
This and other studies have shown the superiority of LPS-free P antigen for tests of delayed hypersensitivity in brucellosis. There seems to be no useful purpose served by the inclusion of LPS in a test antigen, and there are clearly a number of disadvantages. Lipid A is toxic (7) and mitogenic for B cells (1), and the presence of the complete LPS or the PS can result in cutaneous anaphylaxis and Arthus reactions, or both, with resultant confusion of the interpretation. Also, the complete LPS in the antigen can stimulate antibody production that can interfere with subsequent serological diagnosis.
